• LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • Five_100_px
 
Anuncia
  • (978) 942-5600
  • [email protected]
  • Home
  • ABOUT
    • The Anuncia Story
    • Meet the Team
  • RESOURCES
    • News & Blogs
    • Professional Associations
  • For Patients
    • What is Hydrocephalus?
    • Our ReFlow™ Technology
    • Patient Stories
    • Frequently Asked Questions
  • For Clinicians
    • Product Information
  • Investor Relations
  • Careers
  • Contact
  • Menu Menu

Seven Arizona bioscience startups to watch in 2022

February 24, 2022

A regenerative treatment for Alzheimer’s disease, a respiratory-assist device to improve COPD patient care, a blood-based test for colorectal cancer, and a treatment to solve bad dog breath are some of the transformative advances of the 2022 Flinn Foundation Bioscience Entrepreneurship Program participants.

The seven Arizona-based, early-stage companies competitively selected for the foundation’s program will receive $30,000 in funding support through a nonprofit partner, a personalized learning plan, and connections with the state’s bioscience leaders in business, research, and policy.

The 2022 program participants include three Tucson-based startups, two from Phoenix and one each from Scottsdale and Surprise.

“These seven companies are working on innovations and treatments that could dramatically improve millions of lives and make for a healthier world—even for our pets,” said Tammy McLeod, Flinn Foundation president and CEO. “The Flinn Foundation program provides these entrepreneurs with the tools they will need to continue to grow their firms and attract investors.”

To learn more abou tthe 2022 Flinn Foundation Bioscience Entrepreneurship Program participants, click here.

https://anunciamedical.com/wp-content/uploads/2023/03/BEP-logo-2022-1024x576-1.png 576 1024 admin https://anunciamedical.com/wp-content/uploads/2023/12/LowResPNG__Anuncia-Stacked_COLOR_.png admin2022-02-24 19:41:192023-07-26 20:57:17Seven Arizona bioscience startups to watch in 2022

Pages

  • Careers
  • Contact
  • Cookie Policy
  • FAQs
  • For Clinicians
  • Home
  • Investor Relations
  • News & Blogs
  • Our Technology
  • Patient Stories
  • Privacy Policy
  • Professional Associations
  • Publications
  • Thank You!
  • The Anuncia Story
  • What is Hydrocephalus?

Categories

  • Anuncia News
  • Educational Information
  • Press Releases
  • Uncategorized

Archive

  • March 2025
  • June 2024
  • December 2023
  • August 2023
  • July 2023
  • May 2023
  • October 2022
  • March 2022
  • February 2022
  • July 2021
  • June 2021
  • May 2021
  • March 2021
  • May 2019
  • December 2018
  • May 2018
  • February 2018

Contact your physician to discuss if the ReFlow™ System Mini may be right for you.

Additional information about the ReFlow™ System Mini is available by contacting Anuncia.

(978) 942-5600 | [email protected]

Our Address

6908 E Thomas Road
Suite 302
Scottsdale, AZ 85251

Directions

Disclaimer

The ReFlow™ System Mini and ReFlow Mini Flusher are FDA cleared for use in the treatment of patients with hydrocephalus or conditions where draining or shunting of cerebrospinal fluid (CSF) is medically indicated. The ReFlow™ System Mini and ReFlow™ Mini Flusher are not for everyone; please consult your doctor. The ReFlow™ System Mini and ReFlow™ Mini Flusher are only available in the United States. The ReFlow™ System Mini and ReFlow™ Mini Flusher are prescription devices sold by or on the order of a physician.

Caution: FDA (USA) law restricts this device to sale by or on the order of a physician. Refer to product package insert for instructions, warnings, precautions and complications.

Medical Advice Disclaimer

Information on this site is for informational purposes only and should not be used as a substitute for talking with your doctor. No representation is made that the information provided is current, complete, or accurate. Always consult with your doctor about your medical questions, health, diagnosis, and treatment information.

Trademark Legal Notice

All logos, and brands are property of their respective owners in the United States and/or other countries. All company, product and service names used on this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement.

Anuncia Inc. is not affiliated with or an official partner of MD&DI, Fast Company, and The FDA.

© 2024 Anuncia Inc. All Rights Reserved. Website by Honeywick   |   Privacy Policy   |   Cookie Policy
Scroll to top

Contact Us